Chronic kidney disease mineral and bone disorder in children - Wikidata - wikimedia - TriplyDB

Chronic kidney disease mineral and bone disorder in children

Chronic kidney disease mineral and bone disorder in children

http://www.wikidata.org/entity/Q24642788

about

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function.Growth hormone in chronic renal disease.The consequences of chronic kidney disease on bone metabolism and growth in children.Vitamin D status in children with chronic kidney disease Association of bone mineral density with biochemical markers of bone turnover in hemodialysis children.Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels.Case-based education at the 2009 pediatric nephrology fellows conference.Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.Rickets: Part II.Oral Manifestations of Chronic Kidney Disease and Renal Secondary Hyperparathyroidism: A Comparative Review.Severe renal osteodystrophy in early infancy.Clinical and etiological profile of refractory rickets from western India.Defective bone microstructure in hydronephrotic mice: a histomorphometric study in ICR/Mlac-hydro mice.Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.Fractures Related to Metabolic Bone Disease in Children with Congenital Heart Disease.

P2860

Q33715510-532E4192-E195-4CC6-884E-4ABF57B429EA Q33939559-BA1E664A-788C-4773-A1D7-5978E6DCB6EB Q35856044-D7EC59A7-10BD-4E5C-8694-927E4B7FA42B Q36318290-F52D93EC-8236-476D-ABDF-501F3B83E57C Q37109797-47568346-CED7-4883-86CD-6899B8A41E62 Q37291922-26312FC4-91B1-43D7-AE2E-76A2C60CEE7B Q37366411-ABB05606-F7D7-4F23-AE6D-597FBE2533FE Q37683782-7D6965BA-7293-49B9-8EEA-4C38C782D67D Q38034690-8A9FD026-D2CD-4201-BAE0-9E619B54AF0C Q38062365-14A36C56-498C-4B4A-9038-D7A0ABF288DB Q38594647-A8C114ED-5A46-4542-B8CC-E9DB9E8EC8AC Q42742402-A827F573-BD44-41AE-B826-C25C85DAC163 Q43639649-CA71258C-8318-4EC0-92EB-FA608DCE7E7E Q44601523-35A35783-8250-476A-96CC-08EB8B008235 Q46169005-364AA851-8302-42E6-9D4E-1FD7BA27F16B Q53374492-D682384D-B349-46C0-92D4-7FF96B1387FD

P2860

Chronic kidney disease mineral and bone disorder in children

http://www.wikidata.org/entity/Q24642788

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Chronic kidney disease mineral and bone disorder in children

@ast

Chronic kidney disease mineral and bone disorder in children

@en

Chronic kidney disease mineral and bone disorder in children

@nl

type

label

Chronic kidney disease mineral and bone disorder in children

@ast

Chronic kidney disease mineral and bone disorder in children

@en

Chronic kidney disease mineral and bone disorder in children

@nl

prefLabel

Chronic kidney disease mineral and bone disorder in children

@ast

Chronic kidney disease mineral and bone disorder in children

@en

Chronic kidney disease mineral and bone disorder in children

@nl

P1433

Q24642788-CD35DBE7-44F3-43EE-A400-C4921E6BFBC2

P1476

Q24642788-9ABABB64-181C-43E7-A3BB-34678C39A9CF

P2093

Q24642788-08015DBA-83B9-466E-8CF5-42AB322316BD

Q24642788-2D44B6AF-5729-4F61-83A2-07CF54607F83

Q24642788-4B7036F4-0899-42E0-8596-D07AD48D47B1

P2860

Q24642788-00FE20FF-1624-48F2-B859-EE5920A3C207

Q24642788-038A101B-C6E0-4D7F-B59C-36BAED03DF46

Q24642788-067EC245-F0F0-4B9F-8617-23029CB6E7C4

Q24642788-09200839-CB53-45AC-8C30-8BEE20620052

Q24642788-0996CC20-7213-4EF4-9172-3ECC48D74735

Q24642788-122E1729-5D06-46A3-9970-E99F2B7034C4

Q24642788-147F6C87-4EB1-427E-AA07-D92CDE0CD018

Q24642788-175A5606-AC71-46AC-A64B-04A671B44634

Q24642788-18504331-2D37-44B0-94B9-5B97600C6C0A

Q24642788-1959A269-20F7-4115-B983-4559D87A3EED

P2888

Q24642788-AC1F628E-6585-42C4-A48B-F39F52154831

P304

Q24642788-1B6327FF-6D95-483D-AB0A-6BCE3D501129

P31

Q24642788-3DEE1B90-FC74-4AAF-B658-590D3D594FDA

Q24642788-711A4C95-81F6-4412-A308-39FE80DDBB2B

P3181

Q24642788-3EC1A246-ED9F-4A72-82D2-68A6893B87BD

P356

Q24642788-FB046253-84AE-423F-8636-98B60E3C0AEC

P407

Q24642788-51EB3881-BE07-4267-850D-A1961C8067B8

P433

Q24642788-F56A1EE4-5DA5-4B82-BEC5-1B9E32DE60FF

P478

Q24642788-AD7C3CCF-5F53-4FBD-A1B6-14A8B59A5A41

P577

Q24642788-70384D5A-C920-4168-9CB4-1A9DDAF136B1

Q24642788-D8FFDFD7-6958-4BCC-81FA-43488764F0CE

P5875

Q24642788-7369F401-71B4-454B-89C0-F305BA33CBB6

P6179

Q24642788-084A25AA-74B8-4304-97BC-AC46231ECE91

P698

Q24642788-E8B93207-7AD5-471B-809E-767E70956D60

P921

Q24642788-83FBA360-B9EE-4A0C-A81B-4B8F340EE1B8

Q24642788-8C6AD3A8-69AE-4750-A5D4-45B5954EE671

Q24642788-EDD61832-8AA3-4F55-87C1-375B1B941C1F

Q24642788-F4FC8B9A-65C6-4B26-89BE-FA72277110AA

P932

Q24642788-6DD6A188-573C-488A-BEE4-8443C90E8929

P3181

P356

S00467-007-0671-3

P1433

Pediatric Nephrology

P1476

Chronic kidney disease mineral and bone disorder in children

@en

P2093

Isidro Salusky

http://www.w3.org/2001/XMLSchema#string

Katherine Wesseling

http://www.w3.org/2001/XMLSchema#string

Sevcan Bakkaloglu

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

Phosphate regulation of vascular smooth muscle cell calcification

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats

The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

P2888

s00467-007-0671-3

P304

195-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4271488

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00467-007-0671-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5800534

http://www.w3.org/2001/XMLSchema#string

P6179

1005611505

http://www.w3.org/2001/XMLSchema#string

P698

18046581

http://www.w3.org/2001/XMLSchema#string

P921

hypophosphatemia

chronic kidney disease-mineral and bone disorder

chronic kidney disease

P932

2668632

http://www.w3.org/2001/XMLSchema#string